A detailed history of Stone House Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Stone House Investment Management, LLC holds 215 shares of AMGN stock, worth $68,709. This represents 0.02% of its overall portfolio holdings.

Number of Shares
215
Previous 214 0.47%
Holding current value
$68,709
Previous $60,000 11.67%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $262 - $319
1 Added 0.47%
215 $67,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $1,344 - $1,622
5 Added 2.39%
214 $60,000
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $45,258 - $51,057
177 Added 553.13%
209 $60,000
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $7,225 - $8,806
32 New
32 $7,000
Q2 2019

Jul 09, 2019

SELL
$166.7 - $195.41 $4,667 - $5,471
-28 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$180.87 - $203.88 $5,064 - $5,708
28 New
28 $5,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stone House Investment Management, LLC Portfolio

Follow Stone House Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone House Investment Management, LLC with notifications on news.